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Objectives. Psychoactive drugs are group of compounds used to treat severe mental problems, 
including psychosis, as well as other conditions. This study assessed clinically relevant side effects 
of haloperidol and clozapine on the thyroid hormones.
Methods. Haloperidol (0.05 and 2 mg/kg) or clozapine (0.5 and 20 mg/kg) was intraperitoneally 
injected to male Wistar rats for 28 days. The control group received 2 ml of physiological saline. 
A chemiluminescent immunoassay was used to measure the plasma levels of thyroid hormones.
Results. Plasma concentrations of thyroxine (T4) in rats treated with high-dose (2 mg/kg) of 
haloperidol decreased significantly compared to the control group (p=0.001). However, both low 
(0.5 mg/kg) and high clozapine (20 mg/kg) doses did not have a significant effect on the plasma 
concentrations of T4 and triiodothyronine (T3) (p>0.05). Neither of the compound had a signifi-
cant effect on T3 plasma concentration levels (p>0.05).
Conclusions. Haloperidol and clozapine act via different mechanisms and may have dissocia-
ble effects on thyroid hormones. Following treatment with haloperidol, significant changes in T4, 
but not in T3, serum levels were observed. Haloperidol and clozapine had different effects on the 
thyroid hormone levels. These results indicate that antipsychotic treatment can contribute to the 
thyroid dysfunction. Therefore, greater caution should be applied to the antipsychotics use. The 
thyroid function of the patients should be closely monitored, while using these drugs.
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The thyroidal hormone 3,3’-5-triiodo-l-thyronine 
(T3) and its prohormone, l-thyroxine (T4), play key 
roles in lipid, carbohydrate, and protein metabolism 
as well as physiological functions including heart rate, 
neural development, and cardiovascular functioning, 
and renal, brain, and cellular reactions (Jabbar et al. 
2017; Khadem-Ansari et al. 2017). T4 plays a key role 
in the cellular differentiation and acts as an antiapop-
tosis factor. The 5’-deiodination of T4 produces the 
nuclear receptor binding hormone T3, which regu-
lates several physiological and fundamental cellular 
processes in the body, including blood coagulation, 
inflammation, cellular differentiation, body temper-
ature, cell growth and proliferation, dyslipidemia, 
sodium and water homeostasis, and blood pressure 
changes (Hercbergs et al. 2015; Gnocchi et al. 2016). 
The synthesis and storage of the thyroid hormones are 
tightly regulated by a feedback control system because 
of their complex of cellular and physiological roles. 
Two factors affect the synthesis of thyroid hormones: 
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biological factors that affect gene expression, and 
protein kinases and/or ion channels (Chi et al. 2016; 
Gnocchi et al. 2016). The thyroid function and physi-
ology can be altered by drugs indicated for a variety of 
uses in different clinical fields. These compounds may 
affect thyroid gland function by altering the synthesis 
and metabolism of thyroid hormones. Psychotropic 
drugs and antidepressants can interfere with the 
biosynthesis, function, and autoimmunity of thyroid 
hormones (Sauvage et al. 1998; Khalil and Richa 
2011). Many patients with psychological illnesses take 
more than one antipsychotic drug that may affect the 
thyroid physiology. A thorough understanding of 
the effects of these drugs on thyroid metabolism is 
critical (Tandon and Halbreich 2003). The molecular 
mechanisms and potential toxic effects of long-term 
use of antipsychotics have been investigated and must 
be seriously considered (Chen et al. 2016). Clozapine 
and haloperidol are used to treat a variety of mental 
illnesses and psychotic disorders (Sauvage et al. 
1998; Kudo and Ishizaki 1999). Clozapine is gener-
ally considered as one of the most effective antipsy-
chotic drugs and has been used in the management 
of schizophrenia and bipolar disorder for many years 
(Chang et al. 2006; Lin et al. 2012). Haloperidol is a 
potent neuroleptic drug and tranquilizer, broadly 
used in the treatment of delirium, schizophrenia, 
and alcohol withdrawal. It is particularly effective in 
treating the symptoms of psychotic disorders (Muller 
et al. 2016; Zaprutko et al. 2016).
Long-term use of these drugs has an inhibi-
tory effect on CYP 450 isoenzymes in patients with 
schizophrenia and depression (Micallef et al. 2005). 
Several psychoactive drugs have been shown to alter 
thyroid function and production as well as hormone 
transport mechanisms and metabolism (Barbesino 
2010).
This study examined the effects of chronic 
clozapine and haloperidol treatment on T3 and T4 
serum concentrations. Considerable endocrinolog-
ical impacts of chronic haloperidol and clozapine 
treatment on thyroid hormones may occur. Under-
standing the effects of this drug class is critical to 
managing the thyroid abnormalities.
Materials and methods
Chemicals. Haloperidol and clozapine were 
obtained from Sigma Chemicals (St. Louis, MO, 
USA). Other agents used in this research were 
obtained from Merck (Germany).
Drug preparation. A 20 mg/ml stock solution 
of haloperidol was prepared by heating 200 mg of 
haloperidol in 10 ml lactic acid (1%) until dissolved. 
This solution was then diluted with distilled water 
to obtain the 0.5 and 2 mg/ml haloperidol solutions. 
NaOH (1N) was added to adjust the pH of the final 
solutions to 5.1. Clozapine was prepared every day by 
dissolving 140 mg of clozapine in 0.6 ml of HCl (1N) 
at a moderate heat, then diluting the solution with 
distilled water to obtain 0.5 mg/ml. These solutions 
were adjusted with NaOH (1N) to a pH of 5.1.
Animals and drug administration. All proce-
dures and experimental protocols were approved by 
the Ethics Committee of Urmia University (Ir.umsu.
rec.1390.115). Male Wistar rats (weight: 270±30 g; 
age: 14–15 weeks) were ordered from the Depart-
ment of Physiology, Faculty of Medicine, Urmia 
University of Medical Sciences, Urmia, Iran. Animals 
were allowed to acclimatize for 1 week before the 
commencement of the study. The rats were housed 
in ventilated soundproof boxes in filter-top standard 
cages, under a controlled environment with 50% 
humidity at 22 °C and a 12 h light-dark cycle (Khor-
rami et al. 2015). Rats (n=50) were housed two per 
cage with ad libitum access to water and food. After 
the habituation period, rats received daily intra-
peritoneal injections of either low-dose haloperidol 
(0.05 mg/kg, n=10), high-dose haloperidol (2 mg/kg, 
n=10), low-dose clozapine (0.5 mg/kg, n=10), high-
dose clozapine (20 mg/kg, n=10). The control group 
was treated with 2 ml of physiological saline daily 
intraperitoneal injections of normal saline (n=10). 
This dose regimen was designed to imitate the thera-
peutic range of doses given to human patients and 
was shown to be effective in other biochemical and 
behavioral studies (Kapur et al. 2000; Lipska et al. 
2001). All rats received daily injections for 28 days.  
Determination of thyroid hormone (T3 and T4) 
levels. All experiments were started at the same time 
of the day (8.00 a.m.). After the experimental period, 
animals were anesthetized by ether and blood was 
collected by a direct cardiac puncture. Blood samples 
were centrifuged and the isolated serum measured 
and analyzed using the chemiluminescence immu-
noassay (CLIA) method (LIAISON Immunoassay; 
DiaSorin SpA, Saluggia, Italy) and its special kits for 
this set. All efforts were made to minimize animal 
suffering and reduce the number of animals used.
Statistical analysis. Descriptive statistics are 
presented as mean, standard deviation, minimum, 
and maximum values. The normality of T3 and 
T4 serum concentrations were evaluated using the 
Shapiro-Wilk test. The Kruskal-Wallis test was used 
to compare T4 and T3 serum levels among groups. 
Dunn’s test was used for pairwise comparisons. A 
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p-value <0.05 was considered statistically significant. 
Statistical analyses were conducted using IBM SPSS 
Statistics software (ver. 22.0; IBM Corp., Armonk, 
NY, USA).
Results
After 28 days of treatment with clozapine or halo-
peridol, there was a statistically significant differ-
ence in T4 serum levels seen between the control 
and at least one of the treatment groups (Table 1). No 
significant difference in T3 serum levels was observed 
between the treatment groups and the control group 
(p≥0.05). T4 concentrations decreased linearly with 
increased haloperidol dose but showed no change 
with increasing clozapine dose. The Kruskal-Wallis 
test, which is the nonparametric counterpart of 
ANOVA, was used to compare T3 and T4 concen-
trations among groups because the distribution in 
at least one subgroup was not normal (according 
to the Shapiro Wilk’s test). The Kruskal-Wallis test 
indicated a significant difference among the groups 
for T4 (p<0.05). Dunn’s test indicated that the T4 
levels of rats treated with high-dose (2 mg/kg) halo-
peridol decreased significantly compared to controls 
(7.00±0.49 and 8.11±0.51, respectively; p=0.001). 
Additionally, the T4 serum concentration levels of 
rats treated with high-dose clozapine (20 mg/kg) 
were higher than low and high doses of haloperidol 
(8.32±0.10 vs. 7.67±0.32 and 7.00±0.49; p=0.006 and 
p<0.001, respectively).
Descriptive statistics and the results of pairwise 
comparisons of the five groups are shown in Table 1. 
The mean T3 levels of groups 1–5 were 149, 146.50, 
149.80, 148, and 147.20 mg/kg, respectively. No 
significant difference was observed in terms of T3 
serum concentration among the groups (p>0.05).
Low-dose clozapine decreased T4 serum levels, 
while high-dose clozapine elevated T4 levels. Pair-
wise comparisons indicated that these changes in T4 
levels were not statistically significant compared to 
the control group (p=1.000 for both).
Figure 1 presents error bars summarizing changes 
in T3 (mg/kg) and T4 (mg/kg) serum levels by drug 
and dose. Both drugs do not have a significant effect 
on T3 while the high dose of haloperidol suppressed 
T4.
Discussion
Evaluating the thyroidal disorders in patients 
receiving antipsychotic medication presents a partic-
ular challenge. Many drugs have been prescribed 
for the treatment of non-thyroidal conditions and 
have shown efficacy for thyroid function (Baruah 
and Singh 2012). Patients treated with antipsychotic 
medications frequently present with thyroid abnor-
malities and thyroid function disorders (Sabeen et 
al. 2010; Kibirige et al. 2013). Studies have indicated 
that treatment with psychotropic drugs is associ-
ated with altered expression of the nuclear receptors 
and genes involved in thyroid hormone function 
(Langlois et al. 2001).
This study examined the subchronic effects of 
haloperidol and clozapine at two different dosages 
on thyroid hormone levels. Following treatment with 
Table 1
Descriptive statistics of thyroxine (T4) and triiodothyronine (T3) plasma levels according to the treatment groups.
Variables Median Interquartile Range Minimum Maximum p value
T4 (µg/dl)
Control group 8.25a 0.73 7.10 8.80
<0.001
Haloperidol (0.05 mg/kg) 7.70b 0.40 7.00 8.10
Haloperidol (2 mg/kg) 7.00a,c 0.65 6.20 8.00
Clozapine (0.5 mg/kg) 7.83 0.16 7.64 8.20
Clozapine (20 mg/kg) 8.32b,c 0.15 8.17 8.51
T3 (ng/dl)
Control group 148.00 9.50 139.00 158.00
0.727
Haloperidol (0.05 mg/kg) 147.50 9.50 139.00 153.00
Haloperidol (2 mg/kg) 149.50 6.00 143.00 158.00
Clozapine (0.5 mg/kg) 148.00 12.50 136.00 158.00
Clozapine (20 mg/kg) 147.50 9.25 137.00 155.00
Values with the same superscript letters differ significantly (p<0.05).
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haloperidol, significant changes in T4, but not in T3, 
serum concentration levels were observed. Haloper-
idol and clozapine have different effects on thyroid 
hormone levels. These results indicate that antipsy-
chotic treatment can contribute to thyroid dysfunc-
tion, which is consistent with previous research of 
Radhakrishnan et al. (2013), who have observed 
abnormal thyroid hormonal status in a proportion 
of patients with schizophrenia-spectrum disorders. 
In this study, abnormal thyroid hormone status was 
frequently observed in animals treated with antipsy-
chotic drugs. These results may not reflect the preva-
lence of thyroid dysfunction in psychiatric disorders 
in general. In the high-dose haloperidol group, we 
observed a decrease in T4 values. Decreases in T4 
with fluvoxamine were also reported by Hoflich et 
al. (1992). Gitlin et al. (2004) have reported signifi-
cant decreases in T4 values with selective serotonin 
reuptake inhibitor treatment. Lin et al. (2006) have 
demonstrated that chronic treatment with halo-
peridol for 28 days increased T4 and FT4 levels in 
Sprague-Dawley rats.
In this study, high-dose clozapine increased the 
T4 serum concentration, similar to the increase in T4 
values on treatment with reboxetine reported by Eker 
et al. (2008). Studies have reported a decrease in T4 
values, and no significant changes in free T4, values 
after treatment with sertraline (Eker et al. 2008). We 
observed no significant changes in T3 concentrations 
after treatment with haloperidol or clozapine.
Changes in thyroglobulin (Tg) concentration, an 
essential factor for the synthesis of thyroid hormones, 
were observed after treatment with haloperidol and 
alprazolam, in association with alterations in thyroid 
hormones (Samadi et al. 2017). Antidepressants and 
typical and atypical antipsychotic drugs can alter 
thyroid function (Sauvage et al. 1998; Khalil and 
Richa 2011). Elevated serum concentrations of T4 and 
T3 in acute-phase antipsychotic-medicated patients 
has been observed (Bunevicius et al. 2014). In our 
previous study, we observed a decrease in antithy-
roglobulin (aTg) concentrations in rats treated with 
haloperidol and alprazolam (Samadi et al. 2017). 
No significant changes in Tg levels in the haloper-
idol treatment group were observed. Tg levels were 
reduced significantly in rats treated with alprazolam. 
No statistically significant differences in anti-thyroid 
peroxidase (aTPO) antibodie levels between halo-
peridol- and alprazolam-treated rats were observed 
(Samadi et al. 2017). Major changes in thyroid 
hormone concentrations after treatment with halo-
peridol and clozapine were observed.
The results of this study indicate that haloperidol 
interferes with thyroid function. It can, therefore, be 
concluded that there is an association between the use 
of antipsychotic drugs and thyroid function (Samadi 
et al. 2017). Intraperitoneal administration of the 
tricyclic antidepressant desipramine, twice a day for 
14 days, did not alter T3 and T4 levels in rats (Atter-
will et al. 1989). An assessment of thyroid function 
in schizophrenic patients revealed a slight change in 
thyroid axis function, with a major decrease in T4 
serum concentrations in patients taking quetiapine 
(Kelly and Conley 2005).
Baumgartner et al. (2000) have observed signifi-
cant changes in the T4 serum levels of schizophrenic 
patients after 4 weeks of treatment with the pheno-
thiazine derivative perazine. They concluded that 
increased T4 serum levels may be associated with 
acute schizophrenia and that neuroleptic medica-
tion may affect thyroid hormone metabolism. Otten-
weller et al. (1989) have determined that the serum 
Figure 1. Summary of drug-dependent changes in the plasma levels of thyroxine (T4) (A) and triiodothyronine (T3) (B). Haloper-
idol-low and haloperidol-high indicate 0.05 mg/kg and 2 mg/kg, respectively, while clozapine-low and clozapine-high represent 
0.5 mg/kg and 20 mg/kg, respectively.
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hormone levels of hamsters treated with alprazolam 
were similar to those of uninjected healthy and 
cardiomyopathic hamsters. Additionally, T4 levels 
were not affected by alprazolam, while T3 levels 
increased. No significant effects of haloperidol or 
alprazolam treatment on serum TSH levels were 
observed. A significant decrease in antithyroglobulin 
levels in the control group compared to drug-treated 
rats was identified (Samadi et al. 2017). An earlier 
study (Gittoes and Franklyn 1995) has reported high 
serum thyroxine T4 concentrations, with or without 
a decrease in triiodothyronine T3 concentrations, 
similar to the findings of this study.
A variety of therapeutic drugs and compounds can 
affect the concentration of thyroid hormones in the 
blood, which may not be accompanied by clear clin-
ical signs, dysfunction or pathology of the thyroid 
gland. Drugs can affect thyroid function by altering 
mechanisms of metabolism, transport, action, and 
excretion. They may also modulate the regulation of 
the hypothalamic-pituitary-thyroid (HPT) axis and 
cause various abnormalities. Despite useful thera-
peutic applications of antipsychotic drugs, adverse 
effects associated with the dosage and duration of use 
may affect thyroid function. It is critical for clinicians 
to recognize the effects of drugs in laboratory tests, 
to avoid misdiagnosis and unnecessary treatment. 
Patients receiving antipsychotic medications should 
be screened for thyroid function abnormalities regu-
larly after initiating drug treatment.
The mechanisms underlying alterations in thyroid 
hormones in patients treated with antipsychotic medi-
cations remain unclear. Basal thyroid hormone levels 
may affect response to treatment, and antipsychotics 
may affect thyroid hormone levels that in turn affect 
mood. Haloperidol and clozapine act via different 
mechanisms and may have dissociable effects on 
thyroid hormones. This indicates for a existance of 
a complex relationships between neurotransmitter 
systems and the HPT axis. Further studies utilizing 
larger samples are required to investigate the effects 
of antipsychotics on thyroid hormones, to clarify 
these relationships.
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